Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in the Netherlands, 1989-92
| Autor: | P. M. Grosheide, M. A. E. Conyn-Van Spaendonck, J. M. Klokman-Houweling |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
medicine.medical_specialty
Pregnancy Pediatrics Hepatitis B vaccine business.industry General Engineering Prenatal diagnosis General Medicine Hepatitis B medicine.disease Surgery Vaccination Immunization medicine General Earth and Planetary Sciences Gestation Viral disease business General Environmental Science |
| Zdroj: | BMJ. 311:1200-1202 |
| ISSN: | 1468-5833 0959-8138 |
| Popis: | Objectives: To launch a programme for the prevention of perinatal infection with hepatitis B in the Netherlands. Design: Routine antenatal screening and intervention programme. Setting: Community antenatal programme, the Netherlands. Subjects: Infants of mothers who were carriers of hepatitis B detected by routine screening. Interventions: Infants of infected mothers received hepatitis B immunoglobulin at birth and four doses of hepatitis B vaccine in conjunction with routine immunisation at 3, 4, 5, and 11 months of age. Main outcome measures: Results of screening and immunisation from 1989-92. Results: The coverage of screening increased from 46% in 1989 to 84% in 1992. Hepatitis B surface antigen was detected in 2145 women (0.44%). The coverage of postnatal immunoprophylaxis in 1645 neonates born to mothers who were carriers of hepatitis B was 85% (1391); in 3% (42) there was a delay in administration of immunoglobulin of over 24 hours. In 1991, 96% (537), 95% (532), 94% (525), and 87% (489) of the infants received the first, second, third, and fourth dose of vaccine, respectively. There was considerable variation in the timing of vaccination; 17% (258) of the infants received their first dose more than two weeks late. Of the 59% (583) of infants who received the fourth dose more than two weeks beyond target age, 14% (141) also received their first dose too late. Conclusions: A prevention programme for perinatal hepatitis B in an area of low prevalence, when incorporated into existing health care, is feasible and achieves satisfactory coverage rates. Intensive follow up is needed to improve adherence to the immunisation schedule. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|